DG
Entera Bio Pipeline
| Drug | Indication | Phase |
|---|---|---|
| EB613 (oral PTH(1-34)) | Postmenopausal Osteoporosis | Phase 3 Ready |
| EB612 (oral PTH(1-34)) | Hypoparathyroidism | Phase 2 |
| Oral Oxyntomodulin | Obesity | Discovery/Preclinical |
| Oral GLP-2 | Short Bowel Syndrome | Discovery/Preclinical |
| Oral Long-Acting PTH | Hypoparathyroidism | Discovery/Preclinical |